{"id":"W4388588487","doi":"10.1093/neuonc/noad179.0967","title":"QOL-15. THE PIVOTAL TRIDENT STUDY OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Oncology; Concomitant; Internal medicine; Clinical endpoint; Radiation therapy; Chemoradiotherapy; Hazard ratio; Progression-free survival; Clinical trial; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033684,0.00133346,0.001575645,0.000251888,0.0004569336,0.0009017435,0.0006596944,0.0009292423,0.006140762],"category_scores_gemma":[0.001916536,0.0004609373,0.002263352,0.0004902306,0.0007647575,0.0007562995,0.0005911309,0.00209854,0.0009039289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000925858,"about_ca_system_score_gemma":0.002239332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001370081,"about_ca_topic_score_gemma":0.00316181,"domain_scores_codex":[0.9987146,0.0008562366,0.00007602929,0.0001395913,0.00009121243,0.0001223328],"domain_scores_gemma":[0.9982493,0.0002078588,0.0005526581,0.0001140051,0.000194886,0.0006813291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9534512,0.007441065,0.004764003,0.0006617003,0.001709143,0.0000223556,0.00007430563,0.0004832306,0.002920344,0.0002600682,0.004136495,0.02407613],"study_design_scores_gemma":[0.7523326,0.2070893,0.03021679,0.000169022,0.001462094,0.0000789284,0.00006986529,0.0005535909,0.001088093,0.000337457,0.006569036,0.00003321339],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657812,0.005637502,0.000990638,0.001895312,0.0006596177,0.008717328,0.01030808,0.00008598201,0.005924344],"genre_scores_gemma":[0.9502154,0.003026191,0.004406014,0.00246144,0.0004131059,0.02239873,0.01079837,0.00005353291,0.00622722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006140762,"threshold_uncertainty_score":0.02054292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01642223818406499,"score_gpt":0.2852046647349487,"score_spread":0.2687824265508837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}